Debasish Sundi MD

Surgical Oncology

Associate Professor, Urologic Oncology

300 W 10th AveColumbus, OH 43210
Phone+1 614-293-8155
Fax+1 614-293-3565

Dr. Sundi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sundi's full profile Already have an account?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2015 - 2017
Johns Hopkins UniversityResidency, Urology, 2010 - 2015
Johns Hopkins UniversityResidency, Surgery, 2009 - 2010
Northwestern University The Feinberg School of MedicineClass of 2009
Northwestern UniversityBA, Economics, Cum Laude, 2001 - 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 2017 - 2028
TX State Medical License 2015 - 2018
MD State Medical License 2012 - 2013
American Board of Urology Urology

Publications & Presentations

PubMed

Incidence of Germline Genetic Variants in Patients with a Urinary Tract Cancer and Association with Outcomes.
Kent Kamau, Lindsey Byrne, Rajvi Goradia, Debasish Sundi, Lingbin Meng
European Urology Oncology. 2026-08-13
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Thomas W Flaig, Philippe E Spiess, Michael Abern, Yi An, Rick Bangs
Journal of the National Comprehensive Cancer Network. 2026-05-01
ZFP148 is a transcriptional repressor of cytolytic effector CD8T cell differentiation.
Tong Xiao, Xingyu Chen, No-Joon Song, Ryan J Brown, Anjun Ma
Nature Immunology. 2026-04-01

Press Mentions

New Targets for Immunotherapy in Male Cancer Patients: Sex HormonesApril 16th, 2022

Grant Support

MDSC Depletion as a Strategy to Increase Sensitivity of Bladder Cancer to Immune Checkpoint BlockadeAmerican Urological Association - Urology Care Foundation2018–2020